PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Beijing Aldans Biotech Company, Beijing, China.\', \'Department of Oral and Craniofacial Molecular Biology, School of Dentistry, Philips Institute for Oral Health Research, Virginia Commonwealth University, Richmond, Virginia.\', \'Beijing Key Laboratory of Emerging Infectious Diseases, Beijing Ditan Hospital, Institute of Infectious Diseases, Capital Medical University, Beijing, China.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1002/jmv.26009
?:hasPublicationType
?:journal
  • Journal of medical virology
is ?:pmid of
?:pmid
?:pmid
  • 32410266
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.978
?:rankingScore_hIndex
  • 105
?:title
  • Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all